We are so proud to see Dr. Hans Hammers’s clinical trial of RADVAX selected for presentation at ASCO GU 2020. ASCO is the American Society of Clinical Oncology, and ASCO GU focuses on genitourinary cancers.

RADVAX combines SBRT with immunotherapy. This clinical trial showed that high-dose radiation added to immunotherapy can help more patients respond to immunotherapy. Using SBRT to inflame tumors can help the immune system recognize the tumor and therefore increases the response rate to immunotherapy. Higher response rates show that radiation is helping turn some people whose cancer would not respond to immunotherapy (non-responders) into responders.

The encouraging results for kidney cancer patients from this preliminary trial led to the selection of Dr. Hans Hammers and RADVAX for a presentation at ASCO.  

This trial was 100% patient and community funded through the grassroots efforts of Ralph and Brenda Knapp and KidneyCAN.

After impressive response rates, Bristol Myers Squibb has funded this SBRT and immunotherapy combination for continued research, which we hope to see translate quickly to clinical use. Ralph was one of the first patients to receive RADVAX and is pictured here with his wife Brenda and Dr. Hammers. 

Ralph and Brenda Knapp with Dr. Hans Hammers

You can check out Dr. Hammers’s ASCO GU abstract here, but do follow us on Facebook and Twitter to see our live updates of the event this week!

 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Dr. Yousef Zakharia: “I Believe in Teamwork”

Dr. Yousef Zakharia: “I Believe in Teamwork”

For this Community Spotlight feature, we spoke to Dr. Yousef Zakharia, a medical oncologist at the Holden Comprehensive Cancer Center and associate professor at the University of Iowa. Dr. Zakharia shares important information about finding the best care at NCI-designated centers, as well as his...

FALL ADVOCACY DAYS 2023 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Dr. Yousef Zakharia: “I Believe in Teamwork”

Dr. Yousef Zakharia: “I Believe in Teamwork”

For this Community Spotlight feature, we spoke to Dr. Yousef Zakharia, a medical oncologist at the Holden Comprehensive Cancer Center and associate professor at the University of Iowa. Dr. Zakharia shares important information about finding the best care at NCI-designated centers, as well as his...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

CLINICAL TRIALS →

IMMUNOTHERAPY →

OPTIMIZING YOUR KIDNEY HEALTH →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

Dr. Yousef Zakharia: “I Believe in Teamwork”

Dr. Yousef Zakharia: “I Believe in Teamwork”

For this Community Spotlight feature, we spoke to Dr. Yousef Zakharia, a medical oncologist at the Holden Comprehensive Cancer Center and associate professor at the University of Iowa. Dr. Zakharia shares important information about finding the best care at NCI-designated centers, as well as his...

SUPPORT OUR WORK →

ROCK THE RUN 2023 →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Chuck Stravin: “With Time Comes Hope”

Chuck Stravin: “With Time Comes Hope”

Chuck Stravin is married to his high school sweetheart, Liz, and lives in Quincy, Massachusetts, just south of Boston. Diagnosed with advanced renal cancer in 2015, Chuck is beating the odds and has become a passionate advocate for kidney cancer research funding.   For this month's Community...